Rossella Elisei

Rossella Elisei

UNVERIFIED PROFILE

Are you Rossella Elisei?   Register this Author

Register author
Rossella Elisei

Rossella Elisei

Publications by authors named "Rossella Elisei"

Are you Rossella Elisei?   Register this Author

100Publications

1141Reads

mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases.

Mol Cell Endocrinol 2019 Jan 24;479:93-102. Epub 2018 Sep 24.

Department of Surgical, Medical, Molecular Pathology and Critical Area, University Hospital of Pisa, via Savi 10, 56126, Pisa, Italy. Electronic address:

View Article
January 2019

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment.

Front Endocrinol (Lausanne) 2018 9;9:590. Epub 2018 Oct 9.

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

View Article
October 2018

BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer.

J Clin Oncol 2018 Sep 2;36(27):2787-2795. Epub 2018 Aug 2.

Fei Wang, Shihua Zhao, and Yangang Wang, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China; Fei Wang, Xiaopei Shen, Guangwu Zhu, Rengyun Liu, and Mingzhao Xing, Johns Hopkins University School of Medicine, Baltimore, MD; David Viola and Rossella Elisei, University of Pisa, Pisa; Efisio Puxeddu, University of Perugia, Perugia; Laura Fugazzola and Carla Colombo, Istituto Auxologico Italiano, Istituto di Recovero e Cura a Carattere Scientifico (IRCCS), and University of Milan, Milan; Caterina Mian, University of Padua; Federica Vianello, Veneto Institute of Oncology, IRCCS, Padua, Italy; Barbara Jarzab and Agnieszka Czarniecka, Maria Sklodowska-Curie Institute Oncology Center, Gliwice, Poland; Alfred K. Lam, Griffith University, Gold Coast, Queensland; Christine J. O'Neill, Mark S. Sywak, and Roderick Clifton-Bligh, University of Sydney, Sydney, New South Wales, Australia; Linwah Yip, University of Pittsburgh, Pittsburgh, PA; Garcilaso Riesco-Eizaguirre, Hospital Universitario La Paz and Hospital Universitario de Móstoles; Garcilaso Riesco-Eizaguirre and Pilar Santisteban, Biomedical Research Institute "Alberto Sols" and Health Institute Carlos III, Madrid, Spain; and Bela Bendlova and Vlasta Sýkorová, Institute of Endocrinology, Prague, Czech Republic.

View Article
September 2018

Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma.

Head Neck 2018 Aug 22;40(8):1752-1758. Epub 2018 Mar 22.

Department of Surgical, Medical, Molecular Pathology and Critical Area, University Hospital of Pisa, Pisa, Italy.

View Article
August 2018

A patient with MEN1 and end-stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation.

Mol Clin Oncol 2018 Mar 29;8(3):449-452. Epub 2017 Dec 29.

Department of Clinical and Experimental Medicine, Unit of Endocrinology I, University of Pisa, I-56124 Pisa, Italy.

View Article
March 2018

Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer.

J Clin Oncol 2018 Feb 14;36(5):438-445. Epub 2017 Dec 14.

Xiaopei Shen, Guangwu Zhu, Rengyun Liu, and Mingzhao Xing, Johns Hopkins University School of Medicine, Baltimore, MD; David Viola and Rossella Elisei, University of Pisa, Pisa; Efisio Puxeddu, University of Perugia, Perugia; Laura Fugazzola and Carla Colombo, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Auxologico Italiano and University of Milan, Milan; Caterina Mian, University of Padua; Federica Vianello, Veneto Institute of Oncology, IRCCS, Padua, Italy; Barbara Jarzab and Agnieszka Czarniecka, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Alfred K. Lam, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland; Christine J. O'Neill, Mark S. Sywak, and Roderick Clifton-Bligh, The University of Sydney, Sydney, New South Wales, Australia; Linwah Yip, University of Pittsburgh School of Medicine, Pittsburgh, PA; Garcilaso Riesco-Eizaguirre, Hospital Universitario La Paz and Hospital Universitario de Móstoles; Garcilaso Riesco-Eizaguirre and Pilar Santisteban, Biomedical Research Institute "Alberto Sols," Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid; Garcilaso Riesco-Eizaguirre and Pilar Santisteban, Ciberonc, Health Institute Carlos III, Madrid, Spain; and Bela Bendlova and Vlasta Sýkorová, Institute of Endocrinology, Prague, Czech Republic.

View Article
February 2018

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases.

Oncotarget 2018 Feb 4;9(11):9875-9884. Epub 2018 Jan 4.

Endocrine Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy.

View Article
February 2018

Surgical Management of Medullary Thyroid Carcinoma in Pediatric Age.

Curr Pediatr Rev 2016 ;12(4):280-285

Department of Surgical, Medical, Pathological, Molecular and Critic Area, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy..

View Article
December 2017

Role of YAP-1 in Thyroid Tumor Progression and Outcome.

Appl Immunohistochem Mol Morphol 2017 09;25(8):581-585

*Department of Medical Area, Azienda Ospedaliero-Universitaria Pisana, S. Chiara Hospital Departments of †Surgical, Medical, Molecular Pathology and Critical Area ‡Translational Research and of Medical and Surgical New Technologies §Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

View Article
September 2017

KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease.

J Clin Endocrinol Metab 2017 09;102(9):3091-3096

Endocrine Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, 56124 Pisa, Italy.

View Article
September 2017

Calcitonin receptor expression in medullary thyroid carcinoma.

PeerJ 2017 13;5:e3778. Epub 2017 Sep 13.

Cancer Signaling and Metabolism Group, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal.

View Article
September 2017

Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life.

Best Pract Res Clin Endocrinol Metab 2017 06 15;31(3):319-334. Epub 2017 Jun 15.

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Via Paradisa 2, 56124 Pisa, Italy. Electronic address:

View Article
June 2017

Clinical impact of molecular techniques for the presurgical diagnosis of differentiated thyroid cancer diagnosis.

Expert Rev Endocrinol Metab 2017 May 24;12(3):207-214. Epub 2017 Apr 24.

a Endocrine Unit, Department of Clinical and Experimental Medicine , University of Pisa , Pisa , Italy.

View Article
May 2017

Response to Letter: "Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation".

J Clin Endocrinol Metab 2017 05;102(5):1785-1786

Department Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, 56124 Pisa, Italy.

View Article
May 2017

Exploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid.

Eur J Cancer 2017 04 24;75:213-221. Epub 2017 Feb 24.

Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article
April 2017

Inherited variants in genes somatically mutated in thyroid cancer.

PLoS One 2017 14;12(4):e0174995. Epub 2017 Apr 14.

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article
April 2017

Papillary Thyroid Carcinoma With Rare Exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience.

J Clin Endocrinol Metab 2016 11 29;101(11):4413-4420. Epub 2016 Aug 29.

Unit of Surgical Pathology (L.T., E.S., M.G., F.B.), Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine; Endocrine Section (D.V., P.P., C.R., R.E.), Department of Clinical and Experimental Medicine, World Health Organization Collaborating Center for the Study and Treatment of Thyroid Diseases and Other Endocrine and Metabolic Disorders; and Endocrine Surgery Unit (G.M., P.M.), Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa, 56126 Pisa, Italy.

View Article
November 2016

Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer.

Eur Thyroid J 2016 Sep 10;5(3):187-194. Epub 2016 Sep 10.

Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

View Article
September 2016

A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.

Nat Rev Endocrinol 2016 Apr 12;12(4):192-202. Epub 2016 Feb 12.

Endocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy.

View Article
April 2016

Runs of homozygosity and inbreeding in thyroid cancer.

BMC Cancer 2016 Mar 16;16:227. Epub 2016 Mar 16.

Molecular Genetic Epidemiology, C050, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany.

View Article
March 2016

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

J Clin Endocrinol Metab 2016 Jan 3;101(1):264-74. Epub 2015 Nov 3.

Laboratory for Cellular and Molecular Thyroid Research, Division of Endocrinology, Diabetes & Metabolism, Department of Medicine (X.Shi., R.L., X.Shen., D.T., M.X.), Johns Hopkins University School of Medicine, Baltimore, MD 21287; Department of Surgery, Division of Pathology (F.B., R.G.), 56126 Pisa, Italy; The Endocrine Institute and The Liaoning Provincial Key Laboratory of Endocrine Diseases, Department of Endocrinology and Metabolism (H.G., Z.S., W.T.), The First Hospital of China Medical University, Shenyang, Liaoning Province 110001, China; Endocrine Surgery (T.J.M.), University Medical Center, Johannes Gutenberg University Mainz, 55101 Mainz, Germany; Human Cancer Genomic Research (K.A.K.), Research Centre, King Faisal Specialist Hospital and Research Centre, Riyadh 12713, Kingdom of Saudi Arabia; Fondazione Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Policlinico, Milan, and Department of Pathophysiology and Transplantation (L.E., C.C.), University of Milan, 20122 Milan Italy; Endocrine Oncology Branch, Center for Cancer Research (E.K.), National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (A.C., B.J.), 44-101 Gliwice, Poland; Department of Molecular Endocrinology (B.B., V.S.), Institute of Endocrinology, Prague 11694, Czech Republic; Institute of Molecular Pathology and Immunology (Manuel Sobrinho-Simões, M.S.S.; Paula Soares, P.So.), University of Porto (Ipatimup) and Medical Faculty of the University of Porto, 4200-319 Porto, Portugal; College of Medicine (Y.K.S., T.Y.K.), University of Ulsan College of Medicine, Seoul, South Korea; Department of Pathology (S.C.; S.L.A.), University Health Network, Toronto, ON M5G 2C4 Canada; Endocrine Unit, Department of Clinical and Experimental Medicine (D.V., R.E.), World Health Organization, Collaborating Center for the Study and Treatment of Thyroid Diseases and Other Endocrine and Meta

View Article
January 2016

Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group.

J Clin Endocrinol Metab 2015 Dec 29;100(12):4387-95. Epub 2015 Sep 29.

Mayo Clinic (K.C.B.), Rochester, Minnesota, Minnesota 55905; MD Anderson Cancer Center (G.J.C.), Houston, Texas 77030; Translational Genomics Research Institute (M.J.D.), Phoenix, Arizona 85004; University of Pisa (R.E.), 56126 Pisa, Italy; and The Ohio State University and Arthur G. James Comprehensive Cancer Center (S.J., M.D.R.), Columbus Ohio 43210.

View Article
December 2015

Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer.

Eur J Endocrinol 2015 Sep 1;173(3):297-304. Epub 2015 Jun 1.

Endocrine UnitDepartment of Clinical and Experimental MedicineDepartment of SurgicalMedical, Molecular Pathology, University of Pisa, Pisa, Italy andClinical Chemistry LaboratoryAzienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

View Article
September 2015

Medullary thyroid carcinoma in children.

Endocr Dev 2014 29;26:202-13. Epub 2014 Aug 29.

Endocrinology Unit, Department of Clinical and Experimental Medicine, WHO Collaborating Center for the Study and Treatment of Thyroid Diseases and Other Endocrine and Metabolic Disorders, University of Pisa, Pisa, Italy.

View Article
May 2015

Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk.

Sci Rep 2015 Mar 10;5:8922. Epub 2015 Mar 10.

1] Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany [2] Center for Primary Health Care Research, Clinical Research Center, Lund University, Malmö, Sweden.

View Article
March 2015

Effects of radioiodine treatment for differentiated thyroid cancer on testis function.

Clin Endocrinol (Oxf) 2015 Feb 20;82(2):295-9. Epub 2014 Aug 20.

Department of Internal and Experimental Medicine, Section of Endocrinology, University of Pisa Medical School and Hospitals, Presidio di Cisanello, Pisa, Italy.

View Article
February 2015

Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.

J Clin Oncol 2015 Jan 20;33(1):42-50. Epub 2014 Oct 20.

Mingzhao Xing and Ali S. Alzahrani, Johns Hopkins University School of Medicine; Kathryn A. Carson, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD; Young Kee Shong and Tae Yong Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; David Viola and Rossella Elisei, WHO Collaborating Center for the Study and Treatment of Thyroid Diseases and Other Endocrine and Metabolic Disorders, University of Pisa, Pisa; Caterina Mian, University of Padua; Federica Vianello, Veneto Institute of Oncology, Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua; Efisio Puxeddu, University of Perugia, Perugia; Laura Fugazzola, University of Milan and Fondazione IRCCS CàGranda, Milan; Giovanni Tallini, University of Bologna School of Medicine, Bellaria Hospital, Bologna, Italy; Bela Bendlová and Vlasta Sýkorová, Institute of Endocrinology, Prague, Czech Republic; Linwah Yip, University of Pittsburgh School of Medicine, Pittsburgh, PA; R. Michael Tuttle, Eyal Robenshtok, and James A. Fagin, Memorial Sloan-Kettering Cancer Center, New York, NY; Agnieszka Czarniecka and Barbara Jarzab, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Christine J. O'Neill, Mark S. Sywak, and Roderick Clifton-Bligh, University of Sydney, Sydney, New South Wales; Alfred K. Lam, Griffith University School of Medicine, Gold Coast, Queensland, Australia; Garcilaso Riesco-Eizaguirre, Hospital La Paz, Health Research Institute, and Hospital Universitario de Móstoles; Garcilaso Riesco-Eizaguirre and Pilar Santisteban, Biomedical Research Institute Alberto Sols, Spanish Council of Research, and Autonomous University of Madrid, Madrid, Spain; Hirotaka Nakayama, Kanagawa Cancer Center, Yokohama, Japan; and Elizabeth H. Holt, Yale University School of Medicine, New Haven, CT.

View Article
January 2015

Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.

J Clin Endocrinol Metab 2014 Oct 16;99(10):E2084-92. Epub 2014 Jul 16.

Department of Biology (G.F., M.C., E.P., S.L., F.G.), University of Pisa, 56123 Pisa, Italy; Molecular Genetic Epidemiology (A.K., B.C., K.H., A.F.), German Cancer Research Center, 69120 Heidelberg, Germany; Department of Endocrinology and Metabolism (R.E., C.R., A.C.), University of Pisa, 56124 Pisa, Italy; Blood Centre (F.B.), Azienda Ospedaliero Universitaria A. Meyer, 50139 Firenze, Italy; Department of Genomics (P.H., S.H.), Life and Brain Center and Institute of Human Genetics (P.H., S.H.), University of Bonn, D-53127 Bonn, Germany; Division of Medical Genetics (P.H., S.H.), University Hospital Basel and Department of Biomedicine, University of Basel, CH-4058 Basel, Switzerland; Department of Nuclear Medicine and Endocrine Oncology (M.K., D.K., B.J.), Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, 44-101 Gliwice, Poland; Grup de Mutagènesi (S.P., R.M., A.V.), Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallés, Barcelona, Spain; Centro de Investigación Biomédica en Red y Epidemiologia y Salud Pública (S.P., R.M., A.V.), Instituto de Salud Carlos III, 28029 Madrid, Spain; and Center for Primary Health Care Research (K.H., A.F.), Clinical Research Center, Lund University, 205 02 Malmö, Sweden.

View Article
October 2014

Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper.

Eur J Endocrinol 2014 Aug 17;171(2):R33-46. Epub 2014 Apr 17.

Department of Nuclear MedicinePET Centre and Thyroid Unit, Oncology Institute of Southern Switzerland, Bellinzona, SwitzerlandClinical Laboratory ServicesQueen Elizabeth Hospital Birmingham, Birmingham, UKDepartment of Internal Medicine and EndocrinologyFondazione Salvatore Maugeri IRCCS, University of Pavia Hospital, 27100 Pavia, ItalyEndocrine UnitEvgenidion Hospital, University of Athens Medical School, Athens, GreeceDepartment of EndocrinologyUniversity Hospital Pisa, Pisa, ItalyDepartment of EndocrinologyRigshospitalet, Copenhagen University, Copenhagen, DenmarkDepartment of Nuclear MedicinePitié Salpêtrière Hospital, Paris, FranceDepartment of Nuclear MedicineUniversity Hospital Marburg, Marburg, GermanyDivision of EndocrinologyDepartment of Medicine, Helsinki University Central Hospital and University of Helsinki, Helsinki, FinlandDivision of Specific EndocrinologyUniversity Hospital Dusseldorf, Dusseldorf, GermanyDepartment of Nuclear Medicine - Radioisotopic Therapy and Endocrinology UnitInstituto Nazionale Tumori, Milan, ItalySelf-Help Organization of Thyroid Cancer Patients 'Ohne Schilddrüse leben e.V.'Berlin, GermanyDepartment of EndocrinologyUniversity Medical Center St Radboud, Nijmegen, The NetherlandsDepartment of Nuclear MedicineRWTH University Hospital Aachen, Aachen, Germany.

View Article
August 2014

How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level.

Endocrinol Metab Clin North Am 2014 Jun;43(2):331-44

Endocrinology Unit, Department of Clinical and Experimental Medicine, WHO Collaborating Center for the Study and Treatment of Thyroid Diseases and Other Endocrine and Metabolic Disorders, University of Pisa, Via Paradisa 2, Pisa 56124, Italy.

View Article
June 2014

Molecular profiles of papillary thyroid tumors have been changing in the last decades: how could we explain it?

Authors:
Rossella Elisei

J Clin Endocrinol Metab 2014 Feb;99(2):412-4

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, 56124 Pisa, Italy.

View Article
February 2014

Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24.

Cancer Epidemiol Biomarkers Prev 2013 Nov 5;22(11):2121-5. Epub 2013 Sep 5.

Authors' Affiliations: Department of Biology, University of Pisa, Pisa; Center for Integrated Biology, University of Trento, Trento; Department of Endocrinology and Metabolism, Orthopaedics and Traumatology, Occupational Medicine, University of Pisa, Pisa; and Operative Unit of Laboratory of Clinical Chemistry Analyses, University Hospital of Cisanello, Pisa, Italy.

View Article
November 2013

Cabozantinib in progressive medullary thyroid cancer.

J Clin Oncol 2013 Oct 3;31(29):3639-46. Epub 2013 Sep 3.

Rossella Elisei, University of Pisa, Pisa; Lisa Licitra, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico-Istituto Nazionale dei Tumori, Milan, Italy; Martin J. Schlumberger, Institut Gustave Roussy, University Paris-Sud, Villejuif, France; Stefan P. Müller, Universitatsklinikum Essen, Essen; Michael C. Kreissl, Universitätsklinikum Würzburg, Würzburg, Germany; Patrick Schöffski, University Hospitals Leuven, Leuven, Belgium; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Manisha H. Shah, Ohio State University Medical Center, Columbus, OH; Barbara Jarzab, Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie Oddział w Gliwicach, Gliwice, Poland; Viktor Medvedev, Medical Radiological Research Centre of the Russian Academy of Medical Sciences, Obninsk, Russia; Bruno Niederle, Medizinische Universität Wien, Wien, Austria; Ezra E.W. Cohen, University of Chicago, Chicago, IL; Lori J. Wirth, Massachusetts General Hospital, Boston, MA; Haythem Ali, Henry Ford Health System, Detroit, MI; Colin Hessel and Yifah Yaron, Exelixis, South San Francisco, CA; Douglas Ball and Barry Nelkin, Johns Hopkins University School of Medicine, Baltimore, MD; and Steven I. Sherman, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article
October 2013

Medullary thyroid cancer secreting carbohydrate antigen 19-9 (Ca 19-9): a fatal case report.

J Clin Endocrinol Metab 2013 Sep 16;98(9):3550-4. Epub 2013 Jul 16.

Section of Endocrinology, Department of Clinical and Experimental Medicine, and World Health Organization Collaborating Center for the Study and Treatment of Thyroid Diseases and Other Endocrine and Metabolic Disorders, University Hospital of Pisa, 56126 Pisa, Italy.

View Article
September 2013

Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer.

Future Oncol 2013 Aug;9(8):1083-92

Endocrinology Unit, Department of Clinical & Experimental Medicine, WHO Collaborating Center for the Study & Treatment of Thyroid Diseases & other Endocrine & Metabolic Disorders, University of Pisa, Via Paradisa 2, Pisa 56124, Italy.

View Article
August 2013

Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.

J Clin Endocrinol Metab 2013 Jul 26;98(7):2693-700. Epub 2013 Apr 26.

Unit of Endocrinology, Department of Clinical and Experimental Medicine, World Health Organization Collaborating Center for the Study and Treatment of Thyroid Diseases and Other Endocrine and Metabolic Disorders, University of Pisa, 56100 Pisa, Italy.

View Article
July 2013

Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association.

Thyroid Res 2013 Mar 14;6 Suppl 1:S2. Epub 2013 Mar 14.

Department of Endocrinology and Metabolism, University of Pisa, Lungarno Pacinotti 43 - 56126 Pisa, Italy.

View Article
March 2013

Anaplastic thyroid cancer therapy: dream or reality?

Authors:
Rossella Elisei

Endocrine 2012 Dec;42(3):468-70

View Article
December 2012

Modifications in the papillary thyroid cancer gene profile over the last 15 years.

J Clin Endocrinol Metab 2012 Sep 28;97(9):E1758-65. Epub 2012 Jun 28.

Department of Endocrinology and Metabolism and World Health Organization Collaborating Center for the Study and Treatment of Thyroid Diseases and Other Endocrine and Metabolic Disorders, University of Pisa, 56124 Pisa, Italy.

View Article
September 2012

Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma.

Expert Rev Anticancer Ther 2012 Sep;12(9):1137-47

Abramson Cancer Center, Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article
September 2012

RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.

Front Endocrinol (Lausanne) 2012 11;3:54. Epub 2012 Apr 11.

Department of Endocrinology and Metabolism, WHO Collaborating Center for the Study and Treatment of Thyroid Diseases and Other Endocrine and Metabolic Disorders University of Pisa, Pisa, Italy.

View Article
August 2012

Advances in the follow-up of differentiated or medullary thyroid cancer.

Nat Rev Endocrinol 2012 Apr 3;8(8):466-75. Epub 2012 Apr 3.

Department of Endocrinology and Metabolism, University of Pisa, 2 Via Paradisa, 56124 Pisa, Italy.

View Article
April 2012

The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.

J Clin Endocrinol Metab 2012 Feb 7;97(2):426-35. Epub 2011 Dec 7.

Department of Endocrinology and Metabolism, World Health Organization Collaborating Center for the Diagnosis and Treatment of Thyroid Cancer and Other Thyroid Diseases, University of Pisa, Pisa, Italy.

View Article
February 2012

Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma.

Mol Cell Endocrinol 2012 Jan 16;348(1):176-82. Epub 2011 Aug 16.

Department of Endocrinology and Metabolism, University-Hospital of Pisa, 56100 Pisa, Italy.

View Article
January 2012

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.

J Clin Oncol 2012 Jan 24;30(2):134-41. Epub 2011 Oct 24.

Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 13N-240E MSC 1206, 9000 Rockville Pike, Bethesda, MD 20892, USA.

View Article
January 2012

CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.

Eur J Endocrinol 2011 Mar 21;164(3):397-404. Epub 2010 Dec 21.

Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale F. Magrassi e A. Lanzara, Seconda Università di Napoli, 80131 Napoli, Italy.

View Article
March 2011

Acute exogenous TSH administration stimulates leptin secretion in vivo.

Eur J Endocrinol 2010 Jul 14;163(1):63-7. Epub 2010 Apr 14.

Department of Endocrinology and Kidney Dulbecco Telethon Institute at Department of Endocrinology and Kidney University Hospital of Pisa, Via Paradisa, 2, 56124 Pisa, Italy.

View Article
July 2010

Routine serum calcitonin measurement in the evaluation of thyroid nodules.

Authors:
Rossella Elisei

Best Pract Res Clin Endocrinol Metab 2008 Dec;22(6):941-53

Department of Endocrinology, University of Pisa, Via Paradisa 2, Pisa, Italy.

View Article
December 2008

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study.

J Clin Endocrinol Metab 2008 Oct 5;93(10):3943-9. Epub 2008 Aug 5.

Department of Endocrinology, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy.

View Article
October 2008

Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors.

Mol Cell Endocrinol 2008 Sep 14;291(1-2):57-62. Epub 2008 May 14.

Department of Endocrinology and Metabolism, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy.

View Article
September 2008